Review of emerging biomarkers in head and neck squamous cell carcinoma in the era of immunotherapy and targeted therapy
Background Biomarkers in head and neck squamous cell carcinoma (HNSCC) emerge
rapidly in recent years, especially for new targeted therapies and immunotherapies …
rapidly in recent years, especially for new targeted therapies and immunotherapies …
The microRNA-375 as a potentially promising biomarker to predict the prognosis of patients with head and neck or esophageal squamous cell carcinoma: a meta …
P Wang, LL Xu, L Li, SS Ren, JW Tang… - European Archives of …, 2019 - Springer
Background The prognostic value of microRNA-375 (miR-375) expression in squamous cell
carcinoma (SCC) had been reported in the previous studies; however, the results remain …
carcinoma (SCC) had been reported in the previous studies; however, the results remain …
Plasma levels and diagnostic utility of VEGF, MMP-9, and TIMP-1 in the diagnosis of patients with breast cancer
S Ławicki, M Zajkowska, EK Głażewska… - OncoTargets and …, 2016 - Taylor & Francis
Vascular endothelial growth factor (VEGF), matrix metalloproteinase-9, and tissue inhibitor
of metalloproteinase-1 may play a role in the pathogenesis of cancer disease. We …
of metalloproteinase-1 may play a role in the pathogenesis of cancer disease. We …
Upregulation of RUNX1 suppresses proliferation and migration through repressing VEGFA expression in hepatocellular carcinoma
C Liu, D Xu, B Xue, B Liu, J Li, J Huang - Pathology & Oncology Research, 2020 - Springer
Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer, and
occurs in people with chronic liver diseases. Current treatment methods include surgery …
occurs in people with chronic liver diseases. Current treatment methods include surgery …
The efficacy and safety of continuous intravenous endostar treatment combined with concurrent chemoradiotherapy in patients with locally advanced cervical …
H Shu, Y Dong, Z Xu, W Luo, L Xu, H Zhu… - Frontiers in …, 2021 - frontiersin.org
Objective To investigate the short-term efficacy and safety of Endostar combined with
concurrent chemoradiotherapy in the treatment of locally advanced cervical squamous cell …
concurrent chemoradiotherapy in the treatment of locally advanced cervical squamous cell …
[HTML][HTML] Developing a deeper insight into reproductive biomarkers
The development of biomarkers of reproductive medicine is still in its infancy because many
black boxes are still present in reproductive medicine. Novel approaches to human infertility …
black boxes are still present in reproductive medicine. Novel approaches to human infertility …
Novel DOX-MTX nanoparticles improve oral SCC clinical outcome by down regulation of lymph dissemination factor VEGF-C expression in vivo: oral and IV modalities
MM Abbasi, A Monfaredan… - Asian Pacific Journal …, 2014 - koreascience.kr
Background: Oral squamous cell carcinoma (OSCC) remains as one of the most difficult
malignancies to control because of its high propensity for local invasion and cervical lymph …
malignancies to control because of its high propensity for local invasion and cervical lymph …
A Panel of Potential Serum Markers Related to Angiogenesis, Antioxidant Defense and Hypoxia for Differentiating Cutaneous Squamous Cell Carcinomas from Actinic …
SR Georgescu, SM Tocut, C Matei, CD Ene… - Journal of Personalized …, 2024 - mdpi.com
Cutaneous squamous cell carcinoma (cSCC) arising from the malignant proliferation of
epidermal keratinocytes is the second most common skin cancer. Actinic keratosis (AK) …
epidermal keratinocytes is the second most common skin cancer. Actinic keratosis (AK) …
[PDF][PDF] Diagnostic and therapeutic implications of the vascular endothelial growth factor family in cancer
Cancer progression is attained by uncontrolled cell division and metastasis. Increase in
tumor size triggers different vascular channel formation to address cell nutritional demands …
tumor size triggers different vascular channel formation to address cell nutritional demands …
[HTML][HTML] The role of vascular endothelial growth factor in proliferation of odontogenic cysts and tumors: An immunohistochemical study
Background: Vascular endothelial growth factor (VEGF) is capable of initiating angiogenesis
in blood vessels and may act as mitogenic agent for epithelium of odontogenic cysts and …
in blood vessels and may act as mitogenic agent for epithelium of odontogenic cysts and …